Enveric Biosciences Receives Notice of Allowance for Lead Drug Candidate EB-003 from United States Patent and Trademark Office
Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of ...
Pharmabiz7d
Enveric Biosciences receives notice of allowance from USPTO for its drug candidate EB-003 to treat mental health disorders
Enveric Biosciences receives notice of allowance from USPTO for its drug candidate EB-003 to treat mental health disorders: Cambridge, Massachusetts Saturday, February 1, 2025, 13 ...
Enveric Biosciences Expands Mental Health Patent Portfolio With 5 New Additions
This platform includes over 1,000 tryptamine-based molecules ... strong foundation for the long-term success and impact of ...